数字化医疗

Global companies achieving groundbreaking advances in healthcare seek Sidley’s advice on the complex and challenging legal issues they face in their day-to-day business operations. This includes pre-clinical development, evidence generation for market approval and pricing and reimbursement, post-market surveillance, patient and healthcare professional engagement, gathering and analysis of real-world evidence, pharmacovigilance, manufacturing and supply chain, commercial deals, advertising and promotion, data privacy and information security, and the use of AI.

Our deep understanding of the life sciences industry in general, digital health, and AI in particular, is grounded in a collaborative cross-office team that has years of experience working with regulators, service providers, drug and medical device manufacturers, clinical laboratories, genetic testing manufacturers, health technology and health IT companies, industry leaders in consumer technology, and investors in this space. Harnessing our collective knowledge, combined with the resources of the firm’s global network of lawyers across Europe, the United States, and Asia, we help our clients optimize their digital health business models and avoid pitfalls.

Clients comment on Sidley’s “knowledge of the industry and the legal framework” adding that “the firm really makes cases their own” and “act very elegantly before the courts.”
Chambers Global 2022, Multi-Jurisdictional: Life Sciences